Drug intelligence / Profile preview

Avian Influenza Vaccine, H5N1 Subtype, Killed Virus

Development stage: Unknown
Lead developer: Zoetis
Modality: Vaccines & Immunotherapeutics
Administration: Subcutaneous

Overview

Avian Influenza Vaccine, H5N1 Subtype, Killed Virus, developed and manufactured by Zoetis, is a veterinary vaccine designed to prevent disease caused by the H5N1 subtype of avian influenza virus in chickens. As a killed virus vaccine, it contains inactivated viral particles that stimulate the immune system to produce protective antibodies and cellular immunity without causing the actual disease. Zoetis received a conditional license from the USDA for this vaccine, and it has been supplied for the national veterinary stockpile as part of pandemic preparedness efforts.

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on Avian Influenza Vaccine, H5N1 Subtype, Killed Virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avian Influenza Vaccine, H5N1 Subtype, Killed Virus.

Explore the full profile